(Q48294336)

10 February 2018

review article

1 reference

title

Assessing the effects of deprenyl on longevity and antioxidant defenses in different animal models (English)

1 reference

10 February 2018

author name string

Kitani K

1

1 reference

10 February 2018

Kanai S

2

1 reference

10 February 2018

Ivy GO

3

1 reference

10 February 2018

Carrillo MC

4

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 November 1998

1 reference

10 February 2018

Annals of the New York Academy of Sciences

published in

1 reference

10 February 2018

volume

854

1 reference

10 February 2018

page(s)

291-306

1 reference

10 February 2018

The striatal dopamine dependency of life span in male rats. Longevity study with (-)deprenyl

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09910.X

(-) deprenyl induces activities of both superoxide dismutase and catalase but not of glutathione peroxidase in the striatum of young male rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09910.X

The ability of (-)deprenyl to increase superoxide dismutase activities in the rat is tissue and brain region selective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09910.X

(-)Deprenyl increases activities of superoxide dismutase and catalase in striatum but not in hippocampus: the sex and age-related differences in the optimal dose in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09910.X

Sequential changes in activities of superoxide dismutase and catalase in brain regions and liver during (-)deprenyl infusion in male rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09910.X

The optimal dosage of (-)deprenyl for increasing superoxide dismutase activities in several brain regions decreases with age in male Fischer 344 rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09910.X

The effect of a long term (6 months) treatment with (-)deprenyl on antioxidant enzyme activities in selective brain regions in old female Fischer 344 rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09910.X

Chronic treatment of (-)deprenyl prolongs the life span of male Fischer 344 rats. Further evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09910.X

Chronic treatment of Syrian hamsters with low-dose selegiline increases life span in females but not males.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09910.X

Chronic treatment of aged mice with L-deprenyl produces marked striatal MAO-B inhibition but no beneficial effects on survival, motor performance, or nigral lipofuscin accumulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09910.X

L-deprenyl treatment in aged mice slightly increases life spans, and greatly reduces fecundity by aged males.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09910.X

(-)deprenyl increases activities of superoxide dismutase and catalase in certain brain regions in old male mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09910.X

(-)Deprenyl increases activities of superoxide dismutase (SOD) in striatum of dog brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09910.X

Long term treatment with (-)deprenyl reduces the optimal dose as well as the effective dose range for increasing antioxidant enzyme activities in old mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09910.X

Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Parkinson's Disease Research Group of the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09910.X

Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09910.X

Protective effect of deprenyl against 1-methyl-4-phenylpyridinium neurotoxicity in rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09910.X

Deprenyl reduces the death of motoneurons caused by axotomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09910.X

An open-randomized clinical trial of selegiline in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09910.X

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1998.TB09910.X

10.1111/J.1749-6632.1998.TB09910.X

21 January 2018

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018